Clinical trial
An open label, one-arm, multiple dose study in patients with prostate cancer to demonstrate efficacy of a one month goserelin 3.6 mg implant in a two months treatment (2 application periods) and PK/PD analysis of Zoladex� 3.6 mg implant in additional 12 p
To demonstrate that Acino Goserelin 3.6 mg implant is effective in achieving and maintaining castration levels of testosterone.
| Category | Value |
|---|---|
| Study start date | 2011-08-08 |